Key result
Valve-sparing tumor resection via left anterior mini-incision allows uncomplicated day 5 discharge without cardiac arrest.
Why the study?
Pulmonary fibroelastomas are a rare primary cardiac tumor with fewer than 50 cases reported in the literature to date.
Case Report (n=1)
Minimally invasive valve-sparing tumor resection through a left anterior mini-incision is a feasible and safe alternative to median sternotomy for pulmonary fibroelastoma.
May expedite recovery in rare tumors via LAMI; leaves open validation in larger series before practice change.
Pulmonary fibroelastomas are a rare primary cardiac tumor with less than 50 cases reported in the literature to date. We performed a minimally invasive valve-sparing tumor resection through a left anterior mini-incision (LAMI). The procedure was performed without cardiac arrest or aortic cross clamp, expediting postoperative recovery and allowing for an uncomplicated discharge on postoperative day 5. LAMI is a safe and reliable alternative to median sternotomy for patients requiring interventions on the right ventricular outflow tract and main pulmonary artery, including pulmonary fibroelastoma resection and pulmonary valve replacement when needed.
No takes yet. Share an insight, caveat, or question.
Nellis et al. (2019) conducted a case report in Pulmonary fibroelastoma (n=1). Minimally invasive valve-sparing tumor resection through a left anterior mini-incision (LAMI) was evaluated on Postoperative recovery and discharge. Minimally invasive valve-sparing tumor resection through a left anterior mini-incision allowed for an uncomplicated discharge on postoperative day 5 without cardiac arrest or aortic cross clamp.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: